S100B maternal blood levels are gestational age- and gender-dependent in healthy pregnancies

Insights

Maternal S100B protein levels during pregnancy can serve as a non-invasive indicator of fetal central nervous system (CNS) development. This study establishes a reference curve for S100B, aiding in monitoring fetal CNS health.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Obstetrics

Background:

  • S100B protein is a known biomarker for fetal central nervous system (CNS) development and perinatal damage.
  • Fetal CNS activity leads to increased S100B levels detectable in maternal blood.

Purpose of the Study:

  • To establish a reference curve for S100B protein concentrations in maternal blood during the second and third trimesters of healthy pregnancies.
  • To provide insights into fetal CNS development, especially when traditional monitoring methods are limited.

Main Methods:

  • A prospective study involving 1213 healthy pregnancies was conducted between July 2012 and December 2014.
  • Maternal blood samples were analyzed for S100B levels.
  • Multiple forward stepwise regression analysis correlated S100B with gestational age, fetal gender, and delivery outcomes.

Main Results:

  • S100B concentrations varied significantly with gestational age, fetal gender, and delivery mode (p<0.05).
  • A significant positive correlation was observed between maternal S100B levels and gestational age at blood sampling (R=0.13; p<0.001).

Conclusions:

  • The established S100B reference curve in maternal blood indicates the feasibility of non-invasive fetal CNS monitoring.
  • These findings pave the way for further research into neuro-biomarker assessment via maternal blood.
Abstract

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K